Skip to main content
. Author manuscript; available in PMC: 2014 Feb 14.
Published in final edited form as: Clin Nucl Med. 2013 Dec;38(12):949–956. doi: 10.1097/RLU.0000000000000248

FIGURE 1.

FIGURE 1

Tumor-to-background ratio obtained at baseline, 3 to 5 weeks into NAC, and post-NAC for the 19 patients in (A) RCB-0, (B) RCB-1/2, and (C) RCB-3 groups.